Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. SPY

Go back to Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results

Lantheus Holdings (LNTH) Tops Q2 EPS by 4c, Revenues Beat

July 30, 2020 7:30 AM EDT

Lantheus Holdings (NASDAQ: LNTH) reported Q2 EPS of $0.10, $0.04 better than the analyst estimate of $0.06. Revenue for the quarter came in at $66.01 million versus the consensus estimate of $57.4 million.

Completed acquisition of Progenics Pharmaceuticals, Inc., adding robust portfolio of oncology therapeutics and diagnostics to pipelineWorldwide revenue of $66.0 million for the second quarter 2020, representing a decrease of 23.0% from the prior year periodNet loss of $7.0 million for the second quarter 2020, compared to net income of $6.4 million in the prior year... More